| |
| Speaker: Larry Siever, M.D. |
| |
| At the completion of this session, the participant should be able to: |
| |
| 1. Learn that borderline personality disorders have neurobiological substrates. |
| 2. Understand that these substrates provide a rationale for pharmacotherapy. |
| 3. Understand that the neurobiology of borderline personality disorder has implications for psychosocial treatment. |